Search results
From Self-sufficiency
Page title matches
- {{ATC codes lead|N||Nervous system|vet=add}} [[Category:ATC codes|N]]121 bytes (17 words) - 19:24, 27 September 2011
- {{ATC codes lead|P||Antiparasitic products, insecticides and repellents|vet=no}} [[Category:ATC codes|P]]157 bytes (20 words) - 19:24, 27 September 2011
- {{ATC codes lead|R||Respiratory system}} [[Category:ATC codes|R]]117 bytes (15 words) - 19:24, 27 September 2011
- [[Category:ATC codes]] [[ro:Categorie:Formate coduri ATC]]16 members (0 subcategories, 0 files) - 12:10, 19 September 2010
- {{ATC codes lead|G||Genito-urinary system and sex hormones|vet=add}} [[Category:ATC codes|G]]145 bytes (20 words) - 19:19, 27 September 2011
- {{ATC codes lead|C||Cardiovascular system}} [[Category:ATC codes|C]]120 bytes (15 words) - 19:20, 27 September 2011
- {{ATC codes lead|D||Dermatologicals|vet=add}} [[Category:ATC codes|D]]156 bytes (19 words) - 19:20, 27 September 2011
- {{ATC codes lead|A||Alimentary tract and metabolism}} [[Category:ATC codes|A]]130 bytes (17 words) - 19:21, 27 September 2011
- {{ATC codes lead|H||Systemic hormonal preparations, excluding sex hormones and in *Sex hormones are in the ATC group [[ATC code G03|G03]].296 bytes (47 words) - 19:21, 27 September 2011
- {{ATC codes lead|J||Antiinfectives for systemic use|vet=add}} ...globulins and vaccines for veterinary use are in the ATCvet group [[ATCvet code QI|QI]].262 bytes (38 words) - 19:21, 27 September 2011
- {{ATC codes lead|L||Antineoplastic and immunomodulating agents}} [[Category:ATC codes|L]]343 bytes (32 words) - 19:21, 27 September 2011
- {{ATC codes lead|M||Musculo-skeletal system}} [[Category:ATC codes|M]]122 bytes (15 words) - 19:21, 27 September 2011
- {{ATC codes lead|B||Blood and blood forming organs}} [[Category:ATC codes|B]]157 bytes (22 words) - 19:23, 27 September 2011
Page text matches
- ...TCvet code]] | [[Anatomical Therapeutic Chemical Classification System|ATC code]]}} ...TC_suffix|}}} |{{#if:{{{index0|}}} |{{{index0|}}}: }}}}{{Infobox drug/ATC |ATCvet={{{ATCvet|no}}} |ATC_prefix={{{ATC_prefix|}}} |ATC_suffix={{{ATC_su32 KB (3,917 words) - 10:54, 17 June 2016
- | ATC_supplemental = {{ATC|R01|AB05}} {{ATC|R03|CA02}} {{ATC|S01|FB02}} {{ATCvet|G04|BX90}} ...Clin. Toxicol. 41: 849-853, 2003.</ref><ref>WADA. ''The World Anti-Doping Code'', World Anti-Doping Agency, Montreal, Canada, 2010. [http://www.wada-ama.o21 KB (2,906 words) - 16:51, 27 September 2010
- |col4 = [[Template:Neuro procedures|proc]],[[ATC code N|drug]]([[Template:General anesthetics|N1A]]/[[Template:Analgesics|2AB]]/[2 KB (246 words) - 21:37, 20 September 2010
- ...{ATC_supplemental|}}} |{{{ATC_supplemental|}}}|<!--? maint cat:unspecified ATC-->}} ...span title="www.whocc.no/atcvet">[http://www.whocc.no/atcvet/atcvet_index/?code=Q{{{ATC_prefix|}}}{{{ATC_suffix|}}} WHO]</span>)}}<!--820 bytes (109 words) - 10:54, 17 June 2016
- | title = [[Anesthetic]]: [[General anaesthetic|General anesthetics]] ([[ATC code N01#N01A|N01A]])2 KB (199 words) - 15:10, 6 July 2010
- | title = [[Antiparasitic]]s – [[Anthelmintic]]s ([[ATC code P02|P02]])2 KB (239 words) - 15:10, 6 July 2010
- |title = [[Ectoparasiticide]]s / [[arthropod]] ([[ATC code P03#P03A|P03A]])1 KB (119 words) - 15:10, 6 July 2010
- ...[[antiprotozoal agent]]s – [[Chromalveolate]] antiparasitics ([[ATC code P01|P01]])4 KB (337 words) - 15:03, 21 September 2010
- |col4 = [[Template:Endocrine system procedures|proc]], [[ATC code A|drug]] ([[Template:Oral hypoglycemics and insulin analogs|A10]]/[[Templat1 KB (144 words) - 16:26, 19 September 2010
- | title = Oral [[anti-diabetic drug]]s and [[Insulin analog]]s ([[ATC code A10|A10]])3 KB (276 words) - 16:53, 27 September 2010
- ...J01B|J01B]], [[ATC code J01#J01F|J01F]], [[ATC code J01#J01G|J01G]], [[ATC code J01#QJ01XQ|QJ01XQ]])3 KB (308 words) - 12:10, 19 September 2010
- ...sthetic|Local anesthetics]] - primarily [[sodium channel blocker]]s ([[ATC code N01#N01B|N01B]])1 KB (119 words) - 15:10, 6 July 2010
- | title = [[Antiarrhythmic agent]]s ([[ATC code C01#C01B|C01B]])3 KB (298 words) - 12:09, 19 September 2010
- | title = [[Antipruritic]]s ([[ATC code D04|D04]])832 bytes (85 words) - 15:10, 6 July 2010
- |col4 = [[Template:Cardiac procedures|proc]], [[ATC code C|drug]] ([[Template:Cardiac glycosides|C1A]]/[[Template:Antiarrhythmic age1,018 bytes (120 words) - 20:09, 21 September 2010
- |col4 = [[Template:Skin and subcutaneous tissue procedures|proc]], [[ATC code D|drug]] ([[Template:Emollients and protectives|D2]]/[[Template:Preparation2 KB (209 words) - 14:54, 10 December 2011
- | title = [[Throat]] preparations ([[ATC code R02|R02]])1 KB (88 words) - 15:10, 6 July 2010
- | title = [[Vasoprotective]]s ([[ATC code C05|C05]])1 KB (120 words) - 15:10, 6 July 2010
- | title = Anti[[gout]] preparations ([[ATC code M04|M04]])1 KB (95 words) - 16:43, 19 September 2010
- ...ease-modifying antirheumatic drug|antirheumatic]] products / DMARDs ([[ATC code M01#M01C|M01C]])817 bytes (64 words) - 22:11, 19 September 2010